OSI-420
Catalog No. A10678
OSI-420 (Desmethyl Erlotinib,CP-473420)是一种口服活性EGFR酪氨酸激酶抑制剂,可通过抑制细胞间结构域来抑制受体酪氨酸激酶(TKs)。
- Yuta Yamamoto, .et al. Quantitative determination of erlotinib in human serum using competitive enzyme-linked immunosorbent assay, J Pharm Anal, 2018, Apr; 8(2): 119-123 PMID: 29736298
- Janet L. Martin, .et al. Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade, Breast Cancer Res, 2017, 19: 90 PMID: 28778177
Catalog Num | A10678 |
---|---|
M. Wt | 415.9 |
Formula | C21H21N3O4.HCl |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 183320-51-6 |
Synonyms | Desmethyl Erlotinib,CP-473420, OSI420 |
SMILES | COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCO.Cl |
OSI-420 (Desmethyl Erlotinib,CP-473420)是一种口服活性EGFR酪氨酸激酶抑制剂,可通过抑制细胞间结构域来抑制受体酪氨酸激酶(TKs)。
Targets
EGFR | ||||
2 nM |
In vitro | DMSO | Warmed: 75 mg/mL (180.34 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.04 mL | 120.22 mL | 240.44 mL |
0.5 mM | 4.81 mL | 24.04 mL | 48.09 mL |
1 mM | 2.4 mL | 12.02 mL | 24.04 mL |
5 mM | 0.48 mL | 2.4 mL | 4.81 mL |
*The above data is based on the productmolecular weight 415.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.